IP Library Granted Patent US 8,236,359
Granted Patent B2
US 8,236,359 · App. 12/745,315 · Granted Aug 7, 2012

Use of phytoecdysones in the preparation of a composition for acting on the metabolic syndrome

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,236,359
App. No.
12/745,315
Granted
Aug 7, 2012
Kind
B2
Abstract

For reducing the negative effects of the metabolic syndrome on mammal organisms, it is proposed to use phytoecdysones for diminishing the fat body mass in individuals, notably with a weight excess. Phytoecdysones are advantageously incorporated into a food composition. The phytoecdysones can come from food plants, such as quinoa.

Claims (6)

1. A method for diminishing the abdominal fat mass in overweight or obese humans, comprising administering to a human in need thereof, administering a 20-hydroxyecdysone-based composition, wherein the 20-hydroxyecdysone is administered in a dose comprised between 0.3 and 0.5 mg/kg per day, said 20-hydroxyecdysone being supplied as pure 20-hydroxyecdysone or in a saponin-free quinoa extract.

2. The method for diminishing the abdominal fat mass in overweight or obese humans according to claim 1 , wherein human in need thereof has a weight excess or is obese, the human in need thereof suffers from metabolic syndrome, and the metabolic syndrome is treated by diminishing the abdominal fat mass.

3. The method according to claim 1 , wherein the 20-hydroxyecdysone is supplied in the form of a saponin-free quinoa extract comprising between 1% and 7% in weight of the 20-hydroxyecdysone.

4. The method according to claim 3 , wherein the saponin-free quinoa extract comprises 2% in weight of 20-hydroxyecdysone.

5. The method according to claim 1 , wherein the composition is administered in the form of a food or a dietary supplement.

6. The method according to claim 1 , wherein the composition is administered in the form of a medicinal composition.

Assignments (3)
LIEN Recorded Aug 28, 2025
From: BIOPHYTIS S.A.
To: KREOS CAPITAL VI (UK) LIMITED
Reel/Frame 072710/0583 →
CHANGE OF NAME Recorded Sep 6, 2016
From: INSTITUT BIOPHYTIS
To: BIOPHYTIS
Reel/Frame 039918/0246 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 28, 2010
From: VEILLET, STANISLAS; LAFONT, RENE
To: INSTITUT BIOPHYTIS SAS; UNIVERSITE PIERRE ET MARIE CURIE; CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE - CNRS
Reel/Frame 025210/0768 →